Trial Profile
A Post-marketing study of the efficacy and safety of indacaterol in Korean subjects with Chronic Obstructive Pulmonary disease (COPD)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Jan 2016
Price :
$35
*
At a glance
- Drugs Indacaterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 19 Jan 2016 New trial record